Audia James E 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed Nov 8, 2019
Insider Transaction Report
Form 4
Audia James E
Director
Transactions
- Sale
Common Stock
2019-11-06$18.58/sh−10,500$195,076→ 46,534 total - Sale
Common Stock
2019-11-06$17.55/sh−4,500$78,978→ 57,034 total - Sale
Common Stock
2019-11-06$19.11/sh−7,500$143,357→ 39,034 total
Footnotes (4)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $17.39to $17.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $18.00 to $18.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.